SF1 is recurrently mutated across cancers in a mutually exclusive fashion (i.e., indicating its analogous functionality) to RBM10, a gene found to drive aberrant splicing events in cancer (Seiler et al., 2018). This evidence concerns the gene SF1 and cancer.